Frontlight ResearchEarly access
Trial site
Capital Federal
- 10running trials
- 5closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Chronic spontaneous urticaria3 trials
- Coronary artery disease3 trials
- Stroke3 trials
- Chronic myeloid leukaemia2 trials
- Multiple sclerosis2 trials
- Myasthenia gravis2 trials
- Acute lymphoblastic leukaemia1 trial
- Childhood cancers1 trial
- Familial hypercholesterolaemia1 trial
- Giant cell arteritis1 trial
- Hidradenitis suppurativa1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 313 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Active, not recruiting7 trials
- Completed5 trials
- Recruiting3 trials
- Lead sponsor
- Novartis Pharmaceuticals15 trials
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Multiple sclerosis1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026